Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine (Inside Technology)
Language: English
Published by MIT Press, Cambridge, 2003
- First Edition
- Hardcover
- Used

Condition: Used - As new
US$ 45.00
Quantity: 1 available
Add to basketItem description from seller
Unread book in pristine condition. Binding tight. Pages clean and unmarked. Small reaminder mark on bottom of text block. Amazon bar code on back of dustjacket. Since the end of World War II, biology and medicine have merged in remarkably productive ways. In this book Peter Keating and Alberto Cambrosio analyze the transformation of medicine into biomedicine and its consequences, ranging from the recasting of hospital architecture to the redefinition of the human body, disease, and therapeutic practices. To describe this new alignment between the normal and the pathological, the authors introduce the notion of the biomedical platform. Defined as a specific configuration of instruments, individuals, and programs, biomedical platforms generate routines, entities, and activities, held together by standard reagents and protocols. Biological entities such as cell surface markers, oncogenes, and DNA profiles now exist as both normal biological components of the organism and as pathological signs -- that is, as biomedical substances. The notion of a biomedical platform allows researchers interested in the development of contemporary medicine to describe events and processes overlooked by other approaches.The authors focus on a specific biomedical platform known as immunophenotyping. They describe its emergence as an experimental system with roots in biology (immunology) and pathology (oncology). They recount how this experimental system was transformed into a biomedical platform initially for the diagnosis of leukemia and subsequently for other diseases such as AIDS. Through this case study, they show that a biomedical platform is the bench upon which conventions concerning the biological or normal are connected with conventions concerning the medical or pathological. They observe that new platforms are often aligned with existing ones and integrated into an expanding set of clinical-biological strategies.…
Seller Inventory # ABE-1778156174538
- Title
- Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine (Inside Technology)
- Author
- Keating, Peter; Cambrosio, Alberto
- Publisher
- MIT Press, Cambridge
- Publication year
- 2003
- Condition
- As new
- Dust jacket
- Fine
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 0262112760
- ISBN 13
- 9780262112765
- Edition
- 1st Edition
- Item weight
- 1.98 pounds
- Dimensions
- 3.81 centimeters width by 16.51 centimeters height by 23.5 centimeters depth
Since the end of World War II, biology and medicine have merged in remarkablyproductive ways. In this book Peter Keating and Alberto Cambrosio analyze the transformation ofmedicine into biomedicine and its consequences, ranging from the recasting of hospital architectureto the redefinition of the human body, disease, and therapeutic practices. To describe this newalignment between the normal and the pathological, the authors introduce the notion of thebiomedical platform. Defined as a specific configuration of instruments, individuals, and programs,biomedical platforms generate routines, entities, and activities, held together by standard reagentsand protocols. Biological entities such as cell surface markers, oncogenes, and DNA profiles nowexist as both normal biological components of the organism and as pathological signs -- that is, asbiomedical substances. The notion of a biomedical platform allows researchers interested in thedevelopment of contemporary medicine to describe events and processes overlooked by otherapproaches.The authors focus on a specific biomedical platform known as immunophenotyping. Theydescribe its emergence as an experimental system with roots in biology (immunology) and pathology(oncology). They recount how this experimental system was transformed into a biomedical platforminitially for the diagnosis of leukemia and subsequently for other diseases such as AIDS. Throughthis case study, they show that a biomedical platform is the bench upon which conventions concerningthe biological or normal are connected with conventions concerning the medical or pathological. Theyobserve that new platforms are often aligned with existing ones and integrated into an expanding setof clinical-biological strategies.
"Synopsis" may belong to another edition of this title.
About the Author
Peter Keating is Professor of History at the University of Quebec at Montreal.
"About the title" may belong to another edition of this title.
Shipping rates within U.S.A.
| Item | 5 to 14 business days | 3 to 6 business days |
|---|---|---|
| First item | US$ 6.25 | US$ 13.50 |
Payment methods
Store description
Books from the personal collection of a retired anthropologist
Specialty
Non-ficton (social science, history, etc.)Seller's business information
RatBooks
TX, U.S.A.